title: Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases.
abstract: OBJECTIVE
  To quantify the influence of cigarette smoking on the risk of developing rheumatoid arthritis (RA).
  
  
  METHODS
  679 cases and 847 controls included during May 1996-June 2000 in a case-control study, using incident cases, comprising the population aged 18-70 years of a defined area of Sweden, were investigated. A case was defined as a person from the study base who received for the first time a diagnosis of RA using the 1987 American College of Rheumatology criteria, and controls were randomly selected from the study base. Self reported smoking habits among cases and controls, and rheumatoid factor status among cases were registered. The incidence of RA in current smokers, ex-smokers, and ever-smokers, respectively, was compared with that of never-smokers.
  
  
  RESULTS
  Current smokers, ex-smokers, and ever-smokers of both sexes had an increased risk for seropositive RA (for ever-smokers the odds ratio was 1.7 (95% confidence interval (95% CI) 1.2 to 2.3) for women, and 1.9 (95% CI 1.0 to 3.5) for men), but not for seronegative RA. The increased risk was only apparent among subjects who had smoked > or =20 years, was evident at an intensity of smoking of 6-9 cigarettes/day, and remained for up to 10-19 years after smoking cessation. The risk increased with increasing cumulative dose of smoking.
  
  
  CONCLUSIONS
  Smokers of both sexes have an increased risk of developing seropositive, but not seronegative, RA. The increased risk occurs after a long duration, but merely a moderate intensity, of smoking and may remain for several years after smoking cessation.
authors.affiliation: Institute of Environmental Medicine, Karolinska Institutet, Box 210, S-171 77 Stockholm, Sweden. patrikstolt@swipnet.se
authors.forename: P
authors.initials: P
authors.lastname: Stolt
authors.forename: C
authors.initials: C
authors.lastname: Bengtsson
authors.forename: B
authors.initials: B
authors.lastname: Nordmark
authors.forename: S
authors.initials: S
authors.lastname: Lindblad
authors.forename: I
authors.initials: I
authors.lastname: Lundberg
authors.forename: L
authors.initials: L
authors.lastname: Klareskog
authors.forename: L
authors.initials: L
authors.lastname: Alfredsson
mesh_terms: D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000453:epidemiology / Q000209:etiology*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D012217:Rheumatoid Factor / Q000097:blood; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects*; D016540:Smoking Cessation; D013548:Sweden / Q000453:epidemiology
chemical_list: D012217:Rheumatoid Factor